Patients' Perspectives on Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study
Perspectives on the Multidisciplinary Approach to Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study With Patients From the MASH-Cardiovascular Programme at Hospital de Sant Pau i la Santa Creu, Barcelona
1 other identifier
observational
25
1 country
2
Brief Summary
The aim of this qualitative study is to explore and identify the expectations, perceptions, attitudes, needs, and knowledge related to the management of metabolic dysfunction-associated steatohepatitis (MASH) in patients diagnosed with this condition, before and after their participation in the MASH-Cardiovascular Programme at Hospital de la Santa Creu i Sant Pau, Barcelona. The main research question is: What expectations, attitudes, needs, and perceptions do patients with MASH participating in the MASH-Cardiovascular Programme exhibit before and after the intervention? Participants will undergo two semi-structured interviews: one prior to, and one following, their involvement in the MASH-Cardiovascular Programme at Hospital de Sant Pau i la Santa Creu, Barcelona.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2025
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 3, 2025
CompletedFirst Submitted
Initial submission to the registry
July 30, 2025
CompletedFirst Posted
Study publicly available on registry
September 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 20, 2028
September 23, 2025
July 1, 2025
2.5 years
July 30, 2025
September 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Perceptions
Perceptions explored through semi-structured interviews
At baseline (within two weeks before starting the programme) and at one-year follow-up (within two weeks before and after completing the programme)
Attitudes and expectatives
Attitudes and expectatives explored through semi-structured interviews
At baseline (within two weeks before starting the programme) and at one-year follow-up (within two weeks before and after completing the programme)
MASH-related knowledge
MASH-related knowledge explored through semi-structured interviews
At baseline (within two weeks before starting the programme) and at one-year follow-up (within two weeks before and after completing the programme)
Unmet needs
Unmet needs explored through semi-structured interviews
At baseline (within two weeks before starting the programme) and at one-year follow-up (within two weeks before and after completing the programme)
Eligibility Criteria
The study population will consist of individuals diagnosed with MASH who are referred to the multidisciplinary MASH-Cardiovascular Programme at Hospital de la Santa Creu i Sant Pau in Barcelona.
You may qualify if:
- Patients who voluntarily agree to participate in the MASH-Cardiovascular Programme.
- Patients followed in the outpatient hepatology/gastroenterology clinic at Hospital de Sant Pau with a diagnosis of MASH and fibrosis stage F2-F4.
- Patients aged between 18 and 75 years.
- Patients with a BMI ≥ 27 kg/m².
- Patients who consent to participate in the study-specific interviews.
You may not qualify if:
- Patients who do not agree to participate in the study-specific interviews.
- Patients with decompensated liver cirrhosis.
- Patients who are vegetarians or have dietary habits/preferences that prevent adherence to standard-of-care nutritional guidelines.
- Patients with moderate-to-severe alcohol consumption (\>20 g/day for women and \>40 g/day for men).
- Patients with an eGFR \< 30 mL/min.
- Patients with malnutrition.
- Patients with type 1 diabetes or other forms of diabetes.
- Patients who are candidates for bariatric surgery.
- Patients with active malignancy.
- Patients with advanced or unstable heart failure.
- Patients with eating disorders or severe psychiatric illness.
- Patients currently enrolled in another clinical trial.
- Pregnant women or women planning to become pregnant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
IR Sant Pau
Barcelona, 08041, Spain
IR Sant Pau
Barcelona, Spain
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 30, 2025
First Posted
September 23, 2025
Study Start
June 3, 2025
Primary Completion (Estimated)
December 20, 2027
Study Completion (Estimated)
January 20, 2028
Last Updated
September 23, 2025
Record last verified: 2025-07